XT
VRTX icon

XTX Topco’s Vertex Pharmaceuticals VRTX Stock Holding History

XTX Topco’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.98M Buy
+15,632
New +$7.29M 0.12% 158
2025
Q4 		– Sell
-9,690
Closed -$3.79M – 3859
2025
Q3 		$3.79M Buy
9,690
+5,165
+114% +$2.16M 0.2% 64
2025
Q2 		$2.01M Buy
+4,525
New +$2.09M 0.08% 329
2025
Q1 		– Sell
-2,530
Closed -$1.02M – 3178
2024
Q4 		$1.02M Buy
+2,530
New +$1.17M 0.08% 289
2024
Q3 		– Sell
-8,449
Closed -$3.96M – 2657
2024
Q2 		$3.96M Buy
+8,449
New +$3.67M 0.34% 19
2024
Q1 		– Sell
-2,718
Closed -$1.11M – 2368
2023
Q4 		$1.11M Sell
2,718
-4,351
-62% -$1.61M 0.24% 24
2023
Q3 		$2.46M Buy
7,069
+4,270
+153% +$1.49M 0.42% 8
2023
Q2 		$985K Buy
2,799
+1,170
+72% +$394K 0.18% 90
2023
Q1 		$513K Buy
1,629
+774
+91% +$232K 0.11% 276
2022
Q4 		$247K Sell
855
-1,054
-55% -$321K 0.05% 709
2022
Q3 		$553K Buy
1,909
+967
+103% +$278K 0.14% 206
2022
Q2 		$265K Sell
942
-1,239
-57% -$332K 0.11% 324
2022
Q1 		$569K Sell
2,181
-1,073
-33% -$255K 0.25% 113
2021
Q4 		$715K Buy
+3,254
New +$633K 0.4% 38

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

XTX Topco's VRTX Position: Q1 2026 in Review

XTX Topco opened a new position in Vertex Pharmaceuticals (VRTX) in Q1 2026: 15,632 shares worth $6.98M. The stake represents 0.12% of the portfolio and ranks #158 among its holdings. This is a return to the name: XTX Topco previously reported a position in VRTX as recently as Q3 2025.

XTX Topco first reported a position in VRTX in Q4 2021 and has held it in 14 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • XTX Topco held 15,632 shares of Vertex Pharmaceuticals worth $6.98M as of Q1 2026.
  • Vertex Pharmaceuticals was a new XTX Topco position in Q1 2026.
  • Vertex Pharmaceuticals made up 0.12% of XTX Topco's portfolio in Q1 2026, its #158 holding.
  • XTX Topco first reported a position in Vertex Pharmaceuticals in Q4 2021 and has held it in 14 quarters since.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.